If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.



Groups warn against NAFTA patent changes

by Glenn Hess, special to C&EN
February 5, 2018 | A version of this story appeared in Volume 96, Issue 6

A photo of three people at a lectern.
Credit: Associated Press
Ildefonso Guajardo Villarreal of Mexico (left), Chrystia Freeland of Canada (center), and Robert Lighthizer of the U.S. represented their countries at NAFTA negotiations on Jan. 29.

Public health and consumer organizations are urging negotiators updating the North American Free Trade Agreement (NAFTA) to not make changes that would extend patent protections and other benefits for drugmakers. In a Jan. 24 letter to trade ministers, Doctors Without Borders, Consumers Union, and more than 100 other groups from NAFTA partners Canada, Mexico, and the U.S. say the modernized agreement should help reduce health care costs by encouraging the development of more generic drugs. “It is vital that the NAFTA party governments reject any provisions that would expand or strengthen pharmaceutical monopolies and enforcement at the expense of access to affordable medicines,” the groups say. But a coalition of U.S. drug and biotech companies, doctors, and hospitals say the revised pact must strengthen intellectual property protections to foster medical research. Mexico and Canada do not share the U.S.’s commitment to “robust patent rights” that enables pharma to recoup its R&D costs, the Partnership for Chronic Diseases argues in an op-ed. Negotiators will meet in Mexico City later this month for the seventh round of talks on revamping the 24-year-old trade agreement.


This article has been sent to the following recipient:

Chemistry matters. Join us to get the news you need.